Frontiers Association of Lipoprotein(a)-Associated Mortality and
Por um escritor misterioso
Descrição
Frontiers The U-shaped association of non-high-density lipoprotein cholesterol with all-cause and cardiovascular mortality in general adult population
The Remnant Lipoprotein Hypothesis of Diabetes-Associated Cardiovascular Disease
Lipoprotein(a): The next frontier in CV risk reduction
Frontiers Serum lipoprotein (a) associates with the risk of renal function damage in the CHCN-BTH Study: Cross-sectional and Mendelian randomization analyses
Frontiers Coronary Artery Disease: Optimal Lipoprotein(a) for Survival—Lower Is Better? A Large Cohort With 43,647 Patients
Frequent questions and responses on the 2022 lipoprotein(a) consensus statement of the European Atherosclerosis Society - ScienceDirect
Lipoprotein(a) distribution and its association with carotid arteriopathy in the Chinese population - ScienceDirect
Lp(a) (Lipoprotein[a]) Concentrations and Incident Atherosclerotic Cardiovascular Disease
Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular Disease
Frontiers The U-shaped association of non-high-density lipoprotein cholesterol with all-cause and cardiovascular mortality in general adult population
IJERPH, Free Full-Text
Frontiers Lipoprotein(a) in Cardiovascular Diseases: Insight From a Bibliometric Study
LP(a), cardiovascular disease, and all-cause mortality: What's optimal?
de
por adulto (o preço varia de acordo com o tamanho do grupo)
